Physician profile
Ryan W Brower
NPI 1952627663
$1,384.46
in general payments reported to CMS, 2019-2025
17 companies · $122 in 2025
The $122 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $36.98 · 2022: $88.47 · 2023: $796 · 2024: $342 · 2025: $122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,246 · Entertainment: $12.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,246.20 |
| Entertainment | $12.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $332.67 | 2022-2023 | |
| Pfizer INC. | $208.18 | 2023-2025 | |
| Stryker Corporation | $142.64 | 2023 | Infinity, Prophecy |
| Sanofi Pasteur INC. | $125.08 | 2021-2023 | |
| Merck Sharp & Dohme LLC | $116.54 | 2023-2025 | Vaxelis, Gardasil 9, Vaxneuvance |
| Pharming Healthcare, INC. | $90.73 | 2023 | Joenja |
| Phadia US INC. | $83.68 | 2024 | Immunocap |
| Cranial Technologies, INC | $79.33 | 2024-2025 | Doc Band |
| Impulse Dynamics (USA) INC. | $39.49 | 2023-2024 | Optimizer, Optimizer |
| Photonicare INC | $33.84 | 2025 | Otosight Middle Ear Scope |
| Hologic Sales and Service, LLC | $26.70 | 2024 | Aptima |
| Sobi, INC | $20.60 | 2022 | |
| Organon LLC | $20.47 | 2023 | Nexplanon |
| Ultragenyx Pharmaceutical INC. | $19.82 | 2022 | |
| Abbott Laboratories | $18.07 | 2023 | Freestyle Libre 2 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $13.81 | 2023 | Mounjaro |
| Optos, INC. | $12.81 | 2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Brower listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.